Researchers at Keck Medicine of USC demonstrated that Tumor Treating Fields (TTFields), which use alternating electric fields, combined with immunotherapy and chemotherapy, enhance T-cell infiltration and inhibit glioblastoma growth. This synergistic approach offers new hope in treating this aggressive brain cancer with notoriously poor prognosis, potentially expanding therapeutic efficacy by modulating the tumor immune microenvironment.